chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Reports having body aches early in AM so much so that he was unable to complete his normal work out at the gym. He went home to lie down only to awake later that evening with chills, fever, and some mental confusion (his wife reported that he was holding his hand out as if holding a cup but there was no cup there. She called and was advised to give Motrin q 8 hours alternating with Tylenol q 4-6 hours. The confusion and somnolence increased and she again called, spoke with MD who advised to take to ER. He was evaluated at ER, Rx'd with IV's for dehydration and released. Early the next morning, he became increasingly confused and somnolent and developed fecal incontinence. She again called and was advised by he MD to call 911 and return to the ER. He was evaluated there CT scan, MRI and a spinal tap was accomplished that was positive for elevated protein and 20 cells. A consult was obtained and it was decided that VIG was not indicated and the member was transferred to another hospital's ICU. 1/4/06 D/C summary indicates final diagnosis was post-vaccine encephalitis.  1/4/06 Review of medical indicates additional symptoms/conditions include altered mental status, seizure followed by apnea, tachycardia  due to anxiety/agitation, and ataxia.
Received the flu vaccine in Lt deltoid. Next day felt a knot in armpit, the day after felt knot on the Lt side of her neck. 3rd day after receiving the vaccine she felt knots on the lower part of her head and states the knots are now on both sides. Currently rates pain 4/10 on this date, worse when raises head. Sates she is unable to lay down flat due to pain. Knot palpable to Lt side of neck and to bilateral lower head.
tiredness; This is a spontaneous report from a contactable consumer. This consumer reported for his colleague that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication included aspirin [acetylsalicylic acid]. The reporter stated that a colleague of his (unknown age) took aspirin 2 hours before and 2 hours after his Pfizer shot. He told him that he only felt tiredness. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Small red bumps on hand that it looked like papercuts on fingers, and it looked like Blisters. Also, I was getting headaches for around 5-6 days.
2 hours after shot I had the runs (4 times), by 8:00 PM was feeling sick and tired. Had the runs in the night. was still sick in the morning, still had the runs. Was sick and achy and went back to bed after breakfast. woke up about 1:00 PM and had soup for lunch, went back to bed and slept until 3:30 PM, had the runs 2 more times. Felt better by 5:00 PM and had dinner at 6:00 PM. NO FEVER
Urticarial and facial angioedema without respiratory symptoms treated the in ED with epi and discharged with recrudescence of her rash and angioedema several hours later and admitted for observation and symptomatic treatment
Shortness of breath, rapid heartbeat and pulse, high blood pressure, fluid retention in feet and legs, extreme fatigue l
On February 11, 2021,  eight days after my shot, my arm  became itchy, warm, swollen and red patches.  The same arm I received my vaccine in.  I took a Benadryl and applied Benadryl cream on the patches.  It got better in approximately two days with some residual discoloration.
Area around shot swollen & inflamed for two days,  roof of mouth & gums inflamed and painful for 5 days
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age (gravida 1, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The patient's last menstrual period was on 05-Jan-2021 and the estimated date of delivery was 06-Oct-2021. On 20-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Concomitant product use was not provided by the reporter.    Treatment information was not provided.
injection site has gotten progressively more swollen, it's red and itching; injection site has gotten progressively more swollen, it's red and itching; injection site has gotten progressively more swollen, it's red and itching; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2), administration date 09Apr2021 (Batch/Lot number: unknown) at the age of 64 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunisation. The following information was reported: VACCINATION SITE SWELLING (non-serious), VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 2021, outcome "unknown" and all described as "injection site has gotten progressively more swollen, it's red and itching". Therapeutic measures were taken as a result of vaccination site swelling, vaccination site erythema, vaccination site pruritus.  Additional Information: Basically patient wanted to know if she was having an allergic reaction as the injection site has gotten progressively more swollen, it's red and itching. Patient have taken the Benadryl tablet as treatment for events. Patient was just curious to know whether this would be like a mild allergic reaction to the vaccine and should she report it to like physician or tell the people who gave me the shot. Patient have the vaccination card, lot number looks like either 8729, reported that she have no idea what the expiration date is, patient can tell the date when the injection was given, there is only, don't have the expiration date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Case number PHHY2011US63992 is an initial spontaneous report received from a health care professional (pharmacist) on 14 Jul 2011. This report refers to a 32 year old male patient. He was vaccinated with MENVEO (batch number: A00151, expiry date: Jan 2013) 0.5 ml, subcutaneously on 14 Jul 2011. No adverse reaction was reported following this incorrect route of administration.
-Arm soreness started a couple of hours after injection and lasted for about 1 week -warm to touch: started around 10 hours after injection and lasted about 24 hours total - small knot/lump around injection site: started about 12 hours after injection and lasted about 24 hours
Information has been received from a Pharmacist (Pharm.D.) concerning a 48 year old female with no pertinent medical history and no drug reactions/allergies who on 30-SEP-2010, was vaccinated intramuscularly in right deltoid with a 0.5 mL dose of PNEUMOVAX 23 (lot#665904/0866z; exp: 04-Jul-2011). There was no concomitant medication. On the evening of 30-SEP-2010, the patient experienced having difficulty in raising up her arm, "flu-like symptoms", stiffness, pain, and area from the injection site to the elbow were warm. Pharmacist stated patient contacted him and he recommended patient increase fluids, and took diphenhydramine hydrochloride. Pharmacist stated he knew patient did increase her fluid intake but he was not sure if she took any diphenhydramine hydrochloride. At the time of the report, patient had recovered from these adverse events (date not specified). Pharmacist would like lot check. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question (lot # 665904/0866Z) were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center of Biologics Evaluation and Research and was released. Additional information has been requested.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Visual Changes/Disturbances-Mild, Additional Details: After receivig vaccine, patient felt lighthead, blurry vision. Mother said she has a fear of needles and had not eating anything proior vaccine. SShe had some apple juice and ems came and check her out and was fine. did not go to hospital
After 2 weeks, swollen head, rash, very high fevers four weekends in a row; over 105.4F. Vomiting ? the size of ice cubes every nights. Was very sick two months. Shots given by allergist. (Stopped all shots after this!)
Tingling feeling near back teeth on L side and on L side of throat.  No swelling of tongue or throat and no difficulty breathing. Recovering by end of clinic encounter.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 25-JUN-2014, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, exact dose, dose# and route not specified) for the long-term prevention of shingles and/ or zoster-related conditions prescribed and/or administered by a healthcare provider at a pharmacy. On an unspecified date, the patient experienced shingles and was treated by a physician at a hospital. As a direct and proximate result of zoster vaccine live (ZOSTAVAX) vaccine use, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the event was not recovered. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
GAINED 30 POUNDS; CHILLS; LEG PAIN FROM BACK ALL THE WAY DOWN THE LEG FEELING LIKE SCIATICA AND CURRENTLY THE PAIN WAS FROM CALF TO ANKLE; LOST 40 POUNDS; This spontaneous report received from a consumer concerned a 67 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: 19-SEP-2021) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the patient experienced lost 40 pounds. On 21-APR-2021, the patient experienced leg pain from back all the way down the leg feeling like sciatica and currently the pain was from calf to ankle. On 28-JUL-2021, Laboratory data included: Weight loss (not provided) lost 40 pounds. On an unspecified date, the patient experienced gained 30 pounds, and chills. Laboratory data (dates unspecified) included: Blood test (not provided) Negative, Bone marrow biopsy (not provided) Unknown, Colonoscopy (not provided) Unknown, Weight gain (not provided) Gained 30 pounds, and White blood cell count (not provided) 15. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lost 40 pounds on 28-JUL-2021, and chills, had not recovered from leg pain from back all the way down the leg feeling like sciatica and currently the pain was from calf to ankle, and the outcome of gained 30 pounds was not reported. This report was non-serious.
On 17JUN pt began having a temp 103ax; Mom states pt cried all night long; Mom gave APAP 1 tsp & 1 tsp Dimetap q 4 hrs; Pt seen by Md rx Pedizzole Susp. 1/2 tsp q 6 hrs x 10 days;
Patient received 2nd dose of Pfizer via left deltoid.  Approximately 25 minutes later, patient was coughing and had difficulty speaking in full sentences and had audible wheezing.  Pt also complaining of pruritis to injection site.  Approximately 27 minutes post vaccination, pt's 02 sat went from 99% RA to 95% RA.  At that point, pt was given supplemental 02 via NRB, pt took her own 12.5mg Benadryl tablet and was given a cold pack.  Pt conditioned worsened, Epinephrine autoinjector IM given to right thigh.  02 sat went back up to 99%.  EMS arrived on site, pt received duoneb and IV Benadryl 37.5mg, IVP 125mg Solu-medrol.  Pt able to speak in full sentences upon departure to ED.   Vital signs: 1650 bp 160/98, HR 104, 02 99% RA, RR 10. 1700: bp 160/85, 02 95% RA, HR 107, RR 10.  VS after Epinephrine administered, 02 sat returned to 99% on NRB, HR 140, regular rate.  VS by EMS 144/84, 02 sat 98% NRB, HR 84.
Approximately eight weeks subsequent to the administration of the initial Jynneos vaccine on August 8th, 2022, the patient presented on October 8th, 2022, with two purulent abscesses, characterized by significant pain and accompanied by systemic symptoms including fever and chills. The patient reported no prior history of such manifestations. Following the initiation of Doxycycline therapy, as prescribed by the primary care physician, there was noted drainage and resolution of the abscesses, albeit with minor residual scarring. A recurrence of a similar purulent abscess was observed on March 20th, 2023, which similarly responded to Doxycycline treatment. No previous history of such episodes was reported prior to these incidents, and no recurrences have been noted since the last episode.  Photos can be provided.
Less than 12hrs after my vaccine I went into violent shivers.  So extreme that I was beyond my body shaking, my entire body went into a tight/tense state from my toes curled to my teeth gritting down.  Then the exploding pain started in my head.  The best way to describe it was like a bomb went off in my skull.  I was so dizzy/light-headed that even closing my eyes and laying horizontal I was violently spinning.  I became extremely nauseas.  It is the most excruciating pain I have ever been in and I have never reacted to any vaccine, I have definitely received my share of them.  The pain was so bad I had given up hope in making it through it and actively pursued looking for the gun in our house to end my life.  Unfortunately and thankfully I was in such incredible pain that I couldn't focus a thought or begin to move to locate our gun.  It took me two days to begin to get relief.  I contacted a Tricare nurse line and then Community Hospital which then immediately made me an appt to see me.  After running blood test on me my kidneys and liver were failing all their blood test and I had low platelets.  The other symptoms that I faced was brain fog and it was so extreme I could walk into another room in my house and I had no idea where I was.  I was folding laundry and looking at the socks had no idea what I was doing.  I could hold conversations or even read words at times.  After a month my levels normalized, but my legs still throb as if I was running marathons every day.  I now have a constant smell of sulfuric trash and intense headaches have remained with them on a daily basis.
Episodes of crying 30 minutes at a time - difficult to console after 2 month shots - some episodes of screaming - decreased appetite.
Client presented to the vaccination site to receive first dose of Jynneos vaccine lot# FDP00014 on left forearm. Client had also received Covid 19 booster and flu vaccine earlier in the morning at another location(not specified).   While sitting in observation area, client notified RN that he was feeling, ?shaky and sweaty? because he stated, ?I forgot to take my Blood Pressure medication this morning?. RN proceeded to take his vital signs,  PHN, asked client if he had breakfast, client responded, ?No.? A granola bar and water bottle were provided to client. Client was able to move to the gravity chair without assistance. Client denied chest pain, shortness of breath, denied dizziness, and denied itchiness on any part of his body. Client reported a history of high blood pressure and diabetes type 2, and no known allergies. He also stated he had not taken his diabetes medication. Vitals were taken every 5mins. Client was offered to have EMS activated if he didn't feel well due to his blood pressure, Client declined.  Client reported shakiness had subsided and ?Felt better?. client stayed for ten more minutes and finished his water bottle and granola bar provided. Client reported feeling ?better.? Client was no longer shaky. Client reported that last blood pressure reading is normal for when he doesn't take his BP medication. , PHN educated client to seek emergency care if symptoms worsened and to follow- up with his primary care provider. Client verbalized understanding. Client was able to stand up without assistance from gravity chair. Client left vaccination area in a steady gait.
Pt became pale, had LOC, became diaphoretic. After ammonia inhalant used pt awoke and started crying. Vital signs taken. Pt assisted to exam table to lie down. Orange juice given. Vital signs taken 15 minutes later, pt stable.
10-15 min after the injection patients tongue started to get itchy and swollen Was escorted to ER, observed for about 4 hours and dosed with dexamethasone injectable - 6 milligrams (1 time) and diphenhydramine injectable - 25 milligrams (1 time). She notes that she wasn't anxious per se, but felt the tingling and inquired with nurse regarding if what she was feeling was normal or not. It seemed to plateau at 30 min, then within 20 min of dexamethasone and Benadryl her tongue swelling resolved. She had taken cetirizine prior to the vaccination.
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 60-year-old, adult patient of an unspecified gender. It was reported that, the FLUCELVAX QIVc vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 22-Oct-2018, the patient was administered FLUCELVAX QIVc [route of administration: intramuscular, anatomical location: right deltoid, batch number: 252230, expiry date: 31-May-2019 and dose: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805436 was crossed linked to original cases 201804863 due to same reporter.
Swelling and redness from elbow to shoulder of arm in which vaccines were administered; DTaP and PCV7 were administered to left deltoid which is the extremity that experienced swelling.
Really, super itchy eyes; dizziness; This is a spontaneous report from a contactable consumer(patient) via medical information team. A 46-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: ER8732, Expiry Date: Unknown) via an unspecified route of administration, administered in left arm on 30Mar2021 11:30 (at the age of 46 year-old) as dose 1, single for COVID-19 immunization. Medical history included allergies (seasonal allergies): allergic to mold, penicillin, and jalapenos Ongoing from an Unspecified date. There was no Family Medical History Relevant to AE. Concomitant medications was not reported. There was no history of all previous immunization with the Pfizer vaccine considered as suspect and No other Additional Vaccines Administered on Same Date of the Pfizer Suspect. The patient had not received any other vaccine within 4 weeks. It was reported that on 30Mar2021 patient experienced Brief period of dizziness, for 5 seconds then it was gone, she stayed in the waiting room for 10 minutes then drove home. She stated on her way home she had itchy eyes, Really, super itchy eyes at home but now it was gone. She didn't know if the vaccine made her eyes itchy. Reporter stated she would follow up with her HCP if she started having problems breathing and stuff. Adverse event did not require an Emergency Room or Physician Office visit. Reporter queried that as She has seasonal allergies if she could still take her Claritin and Flonase was it okay to take Claritin after the vaccine. And also stated she did not take these before the vaccine because she was not sure if she could. However, she had some major itchy eyes, but it has subsided. There was no relevant Tests. Treatment was Not provided. Reporter seriousness for the events were Unspecified. The Outcome of the events were recovered on 30Mar2021.  No follow-up attempts are needed. No further information is expected.
Pain in the upper left arm where shot was administered, starting 2 days after shot, lessening and then coming back much stronger after 1 week. Soreness and pain from shoulder to elbow. 3 Advil does not alleviate.
tested positive; tested positive/experienced more like a cold; This is a spontaneous report from a Pfizer sponsored program Pfizer First Connect from a contactable consumer (patient).  A 75-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  She had my first shot last month.  Her 2nd shot on 12th Feb, daughter came with Covid tested positive, also her co-worker. 1st of Feb. She was also tested positive. She experienced more like a cold, She would like to know if she should take the 2nd shot.The patient underwent lab tests and procedures which included sars-cov-2 test: positive  in Feb2021. Outcome of events was unknown.  Information on lot/batch number has been requested.
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On 10-SEP-2014 the patient was vaccinated with VARIVAX (Merck) (dose, units, route of administration, anatomical location were not reported) which was exposed to a supported temperature excursion on 15-AUG-2014. No adverse events had been observed or reported. This is one of several reports from the same reporter. Additional information has been requested.
Moderna vaccine received 25-Feb-2021 and Pfizer vaccine received 25-Mar-2021; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Moderna vaccine received 25-Feb-2021 and Pfizer vaccine received 25-Mar-2021) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Moderna vaccine received 25-Feb-2021 and Pfizer vaccine received 25-Mar-2021). On 25-Feb-2021, INTERCHANGE OF VACCINE PRODUCTS (Moderna vaccine received 25-Feb-2021 and Pfizer vaccine received 25-Mar-2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was provide. Treatment information was not provided.